Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine Versus Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia

NCT01495481 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT01495481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01495481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine Versus Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
July 31, 2014
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

supraventricular tachycardia